[ET Net News Agency, 31 January 2024] JD HEALTH (06618) fell 4.9% to HK$25.45.
It hits an intra-day low of HK$25.4, hitting a historical low, and an intra-day high of
HK$26.95. The total shares traded was 4.82 million, with a value of HK$125.84m. The active
buy/sell ratio is 53:47, with net buying turnover of HK$6.46m. GOLDMAN SACHS (ASIA) SEC
accounts for greatest net responsive buying turnover of HK$6.7m, with volume weighted
average price of HK$26.103. MERRILL LYNCH FE accounts for greatest net responsive selling
turnover of HK$10.23m, with volume weighted average price of HK$26.218. The stock has
fallen a combined 12.7% over the past 4 consecutive trading days.
RMB counter of JD HEALTH (86618) fell 4.1% to RMB23.5. It hits an intra-day low of
RMB24.4, and an intra-day high of RMB24.4. The total shares traded was 150, with a value
of RMB3,660.
The Hang Seng Index now fell 245 points, or 1.6% to 15,458; the Hang Seng China
Enterprises Index now fell 92 points, or 1.7% to 5,183; the Hang Seng TECH Index now fell
103 points, or 3.3% to 2,995.

Basic Information
=================

----------------------------------
Nominal 25.450 % Chg -4.86%
High 26.950 Low 25.400
Shares Tr 4.82m Turnover 125.84m
10-D SMA 27.725 %H.V 57.104
20-D SMA 29.940 VWAP 26.127
50-D SMA 34.703 RSI14 27.354
----------------------------------
Status: Hitting a historical low, active buy/sell ratio is 53:47, with net buying turnover
of HK$6.46m, falling a combined 12.7% over the past 4 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
JD HEALTH (06618) 25.45 -4.86
ALI HEALTH (00241) 2.84 -5.33
TRAD CHI MED (00570) 2.99 -0.66
CSPC PHARMA (01093) 5.71 -2.56
SINOPHARM (01099) 20.55 -0.48
SINO BIOPHARM (01177) 2.80 -2.44
CHINARES PHARMA (03320) 4.73 -3.07
HANSOH PHARMA (03692) 11.64 -4.59
SCICLONE PHARMA (06600) 11.02 -5.00
JD HEALTH-R (86618) RMB23.50 -4.08
-----------------------------------------------
(ed)